PD Dr. med. Nina Sophie Schmidt-Hegemann

Prof. Dr. med. Nina-Sophie Schmidt-Hegemann is a highly accomplished radiation oncologist currently serving as the Deputy Director and Senior Physician at the Clinic and Polyclinic for Radiation Therapy and Radiooncology at the LMU Hospital in Munich. Her primary clinical expertise is dedicated to the complex management of urological tumors—with a major emphasis on prostate cancer—and soft tissue sarcomas. Clinically, she is at the forefront of implementing advanced, precision-based radiotherapy techniques. This includes pioneering the use of MR-guided stereotactic ablative radiotherapy for peripheral lung metastases and utilizing PSMA-PET/CT imaging to guide highly targeted salvage radiotherapy in patients with recurrent prostate cancer. Additionally, her formal qualification in palliative medicine underscores a holistic approach to patient care, ensuring that oncological efficacy is carefully balanced with symptom management and quality of life. Beyond her clinical leadership, Prof. Schmidt-Hegemann is a prolific researcher and an influential voice in shaping both national and international oncological guidelines. She is an active member of the German S3 Guideline Commission for Prostate Cancer and a contributing expert to the European ESTRO-ACROP clinical guidelines. Her recent research portfolio is notably forward-thinking, intersecting advanced technology with patient-centered care. She leads innovative studies evaluating the role of Artificial Intelligence and Large Language Models, such as ChatGPT, in improving patient education and health literacy in radiation oncology. Furthermore, she actively investigates the impact of lifestyle interventions, such as aerobic and resistance training, on mitigating treatment-related side effects and improving the physical fitness and overall well-being of prostate cancer patients undergoing radiotherapy.